CVE:ADK ISIN:CA2524423068

DIAGNOSDIAGNOS (CVE:ADK) (OTCMKTS:DGNOF) is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its FLAIRE Artificial Intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications such as CARA (Computer Assisted Retina Analysis). CARA's AI-based image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients. CARA has been cleared for commercialization by the following regulators: Health Canada, the FDA (USA), CE (Europe), COFEPRIS (Mexico) and Saudi FDA (Saudi Arabia).

Additional information is available at www.diagnos.com and www.sedar.com



IRIS Teams up with DIAGNOS Inc (CVE:ADK) in a Multi-Year Agreement to Implement Artificial Intelligence Technology with Support From the INVEST-AI Program

🕔6/10/2021 1:05:10 AM 21557

Diagnos Inc. (CVE:ADK) (OTCMKTS:DGNOF) (4D4A.F), a leader in early detection of critical health issues, is pleased to announce the signing of a multi-year agreement with IRIS The Visual Group (1990) Inc.

Read Full Article

DIAGNOS (CVE:ADK) Enters into Exclusive Distribution Agreement to Access Massive Global Healthcare Market in DACH Countries and Central Europe of Over 140 Million People

🕔4/7/2021 8:35:51 AM 30823

Diagnos Inc. (CVE:ADK) (OTCMKTS:DGNOF) (FRA:4D4A), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the signing of an exclusive distribution agreement with Diagnos Europe GmbH.

Read Full Article


  • This Page Viewed: (Last 7 Days: 25) (Last 30 Days: 77) (Since Published: 2050) 

Company Data

  • 7005 Taschereau Blvd., Suite 265
    Brossard, QC J4Z 1A7
  • Telephone
  • +1-450-678-8882 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.diagnos.ca/
  • E:
  • info@diagnos.com